Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation.

IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY European journal of hospital pharmacy : science and practice Pub Date : 2025-03-23 DOI:10.1136/ejhpharm-2024-004441
Laura Négrier, Marine Roche, Damien Lannoy, Christophe Berneron, Léa Pacqueu, Christophe Carnoy, Antoine Guillon, Benjamin Hamzé, Jean-Claude Sirard, Bertrand Décaudin, Pascal Odou, Cécile Danel
{"title":"Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation.","authors":"Laura Négrier, Marine Roche, Damien Lannoy, Christophe Berneron, Léa Pacqueu, Christophe Carnoy, Antoine Guillon, Benjamin Hamzé, Jean-Claude Sirard, Bertrand Décaudin, Pascal Odou, Cécile Danel","doi":"10.1136/ejhpharm-2024-004441","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To assess the long-term physicochemical stability of a solvent (10 mM phosphate buffer pH 6.5 containing sodium chloride (145 mM) and polysorbate 80 (PS80) 0.02%) used to reconstitute a biologic for nebulisation. The solvent was compounded in the hospital pharmacy and stored in amber glass vials at -20°C for 1 year.</p><p><strong>Methods: </strong>Samples were analysed immediately on compounding and then 1, 3, 6, 9 and 12 months after storage at -20°C (immediately after thawing, and also 1 month later keeping the vials at 2-8°C). The assays included a visual examination, measurement of the pH, osmolality, sub-visible particulate contamination, the concentration of PS80, and the concentration of oleic acid and peroxides (both major markers of PS80 degradation). Quantification of PS80 was challenging due to the substance's molecular heterogeneity and the lack of a good chromophore. The strategy adopted consisted of hydrolysis in a strong base and then liquid-liquid extraction of the oleic acid (PS80's hydrolysis product). The oleic acid content was determined using reversed phase high performance liquid chromatography with ultraviolet detection. The peroxide content was determined spectrophotometrically using a ferrous oxidation with xylenol orange assay.</p><p><strong>Results: </strong>Over 12 months, there was no significant change in the samples' visual appearance, pH and osmolality. The PS80 concentration remained above 90% of the initial value. The subvisible particle counts remained far below the European Pharmacopoeia thresholds. The oleic acid content of the non-hydrolysed samples remained constant, and no peroxide was detected.</p><p><strong>Conclusions: </strong>A PS80-containing solvent is stable for 1 year when stored at -20°C (±5°C) in amber glass vials. Moreover, the solvent is stable for up to 1 month after thawing if stored at 2-8°C.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of hospital pharmacy : science and practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-004441","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To assess the long-term physicochemical stability of a solvent (10 mM phosphate buffer pH 6.5 containing sodium chloride (145 mM) and polysorbate 80 (PS80) 0.02%) used to reconstitute a biologic for nebulisation. The solvent was compounded in the hospital pharmacy and stored in amber glass vials at -20°C for 1 year.

Methods: Samples were analysed immediately on compounding and then 1, 3, 6, 9 and 12 months after storage at -20°C (immediately after thawing, and also 1 month later keeping the vials at 2-8°C). The assays included a visual examination, measurement of the pH, osmolality, sub-visible particulate contamination, the concentration of PS80, and the concentration of oleic acid and peroxides (both major markers of PS80 degradation). Quantification of PS80 was challenging due to the substance's molecular heterogeneity and the lack of a good chromophore. The strategy adopted consisted of hydrolysis in a strong base and then liquid-liquid extraction of the oleic acid (PS80's hydrolysis product). The oleic acid content was determined using reversed phase high performance liquid chromatography with ultraviolet detection. The peroxide content was determined spectrophotometrically using a ferrous oxidation with xylenol orange assay.

Results: Over 12 months, there was no significant change in the samples' visual appearance, pH and osmolality. The PS80 concentration remained above 90% of the initial value. The subvisible particle counts remained far below the European Pharmacopoeia thresholds. The oleic acid content of the non-hydrolysed samples remained constant, and no peroxide was detected.

Conclusions: A PS80-containing solvent is stable for 1 year when stored at -20°C (±5°C) in amber glass vials. Moreover, the solvent is stable for up to 1 month after thawing if stored at 2-8°C.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种含聚山梨酯-80的溶剂在医院药房合成并用于重新配制喷雾剂的物理化学稳定性。
目的:评估用于重建雾化生物制剂的溶剂(10 mM磷酸盐缓冲液pH 6.5,含氯化钠(145 mM)和聚山梨酸80 (PS80) 0.02%)的长期物理化学稳定性。溶剂在医院药房配制,并在-20°C下保存1年。方法:样品在配制时立即进行分析,然后在-20°C保存1、3、6、9和12个月后(解冻后立即进行分析,并在2-8°C保存1个月后进行分析)。检测包括目测、pH值、渗透压、亚可见颗粒污染、PS80浓度、油酸和过氧化物浓度(两者都是PS80降解的主要标志)。由于该物质的分子异质性和缺乏良好的发色团,PS80的定量具有挑战性。采用的策略是在强碱中水解,然后液液萃取油酸(PS80的水解产物)。采用紫外检测反相高效液相色谱法测定油酸含量。过氧化氢的含量用亚铁氧化-二甲酚橙分光光度法测定。结果:在12个月的时间里,样品的外观、pH值和渗透压没有明显变化。PS80浓度维持在初始值的90%以上。可见颗粒数仍远低于欧洲药典的阈值。未水解样品的油酸含量保持不变,且未检测到过氧化物。结论:含ps80的溶剂在-20°C(±5°C)的琥珀色玻璃瓶中可稳定保存1年。此外,如果在2-8°C下储存,溶剂在解冻后稳定长达1个月。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.40
自引率
5.90%
发文量
104
审稿时长
6-12 weeks
期刊介绍: European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.
期刊最新文献
The secret life of the surgical pharmacy in high risk periods. Using local clinical rules in a pharmacy service to detect risk prescriptions in older adult hospital inpatients: a proof-of-concept study. Putting FAERS data into perspective: cautionary considerations for comparative safety assessment. Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainment. Analysis of a serious adverse reaction of rhabdomyolysis precipitated by a possible interaction of methylprednisolone with atorvastatin: a case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1